Meloxicam ampoule

DRUG4 trials

Sponsors

Boehringer Ingelheim, Istanbul Medeniyet University

Conditions

Arthritis, RheumatoidHealthyMesotherapyNeck PainOsteoarthritis

Phase 1

Pharmacokinetics and Tolerability of Meloxicam Injected Intramuscularly vs. Tablet in Healthy Subjects

CompletedNCT02183090

Boehringer IngelheimHealthy

Start: 1998-11-30Updated: 2014-07-08

Phase 3

A Study to Compare Meloxicam IM Once Daily and Meloxicam Administered Orally Once Daily in Patients With Osteoarthritis

CompletedNCT00239395

Boehringer IngelheimOsteoarthritis

Start: 2004-07-31End: 2004-12-31Target: 168Updated: 2013-11-01

A Study to Compare Meloxicam IM Once Daily Versus Meloxicam Orally Once Daily in Patients With Rheumatoid Arthritis

CompletedNCT00239382

Boehringer IngelheimArthritis, Rheumatoid

Start: 2004-07-01End: 2004-12-31Target: 150Updated: 2018-08-03

Unknown Phase

Comparison of Mesotherapy Treatment Doses in Patients With Chronic Non-Specific Neck Pain

CompletedNCT07462988

Istanbul Medeniyet UniversityMesotherapy, Neck Pain

Start: 2025-01-01End: 2025-11-01Updated: 2026-03-10